Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Novartis Oncology - Removing the brakes on the immune system: Gearing up for tumor-promoting inflammation inhibitors in NSCLC

Immunotherapy in the rearview mirror: Successes and remaining unmet needs

Date

28 Sep 2019

Session

Novartis Oncology - Removing the brakes on the immune system: Gearing up for tumor-promoting inflammation inhibitors in NSCLC

Presenters

Alistair Greystoke

Authors

A. Greystoke

Author affiliations

  • Northern Centre For Cancer Care, Newcastle upon Tyne Hospitals, Newcastle upon Tyne/GB
More

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings